219 related articles for article (PubMed ID: 26198547)
41. The effect of heparan sulphate on the crystallization of calcium oxalate in undiluted, ultrafiltered human urine.
Suzuki K; Ryall RL
Br J Urol; 1996 Jul; 78(1):15-21. PubMed ID: 8795393
[TBL] [Abstract][Full Text] [Related]
42. Strain differences in urinary factors that promote calcium oxalate crystal formation in the kidneys of ethylene glycol-treated rats.
Li Y; McMartin KE
Am J Physiol Renal Physiol; 2009 May; 296(5):F1080-7. PubMed ID: 19244400
[TBL] [Abstract][Full Text] [Related]
43. Changes in calcium oxalate crystal morphology as a function of supersaturation.
Carvalho M; Vieira MA
Int Braz J Urol; 2004; 30(3):205-8; discussion 209. PubMed ID: 15689248
[TBL] [Abstract][Full Text] [Related]
44. Does Tamm-Horsfall mucoprotein inhibit or promote calcium oxalate crystallization in human urine?
Grover PK; Ryall RL; Marshall VR
Clin Chim Acta; 1990 Oct; 190(3):223-38. PubMed ID: 2253402
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of calcium oxalate crystallization by urinary macromolecules.
Bek-Jensen H; Tiselius HG
Urol Res; 1991; 19(3):165-9. PubMed ID: 1887524
[TBL] [Abstract][Full Text] [Related]
46. Calcium oxalate crystallization in undiluted postprandial urine of healthy male volunteers as influenced by citrate.
Fan J; Schwille PO; Schmiedl A; Fink E; Manoharan M
Arzneimittelforschung; 2001 Oct; 51(10):848-57. PubMed ID: 11715639
[TBL] [Abstract][Full Text] [Related]
47. Investigation of the possible role of sialic acid in calcium oxalate urolithiasis.
Yoshimura K; Yoshioka T; Miyake O; Honda M; Koide T; Okuyama A
Eur Urol; 1998; 33(1):111-5. PubMed ID: 9471052
[TBL] [Abstract][Full Text] [Related]
48. Total flavonoids of Desmodium styracifolium attenuates the formation of hydroxy-L-proline-induced calcium oxalate urolithiasis in rats.
Zhou J; Jin J; Li X; Zhao Z; Zhang L; Wang Q; Li J; Zhang Q; Xiang S
Urolithiasis; 2018 Jun; 46(3):231-241. PubMed ID: 28567512
[TBL] [Abstract][Full Text] [Related]
49. Calcium oxalate nephrolithiasis: urinary "medium size peptides"analysis using MALDI-TOF mass spectrometry.
D'Addessi A; Bongiovanni L; Vittori M; Fanali C; Foschi N; Castagnola M; Bassi PF
Arch Ital Urol Androl; 2010 Sep; 82(3):140-4. PubMed ID: 21121430
[TBL] [Abstract][Full Text] [Related]
50. Metabolic stress response patterns in urinary compositions of idiopathic calcium oxalate stone formers, patients with chronic bowel diseases and controls.
Berg W; Gayde S; Uhlemann C; Laube N
Urol Res; 2010 Jun; 38(3):161-8. PubMed ID: 20440612
[TBL] [Abstract][Full Text] [Related]
51. Calcium oxalate crystal matrix extract: the most potent macromolecular inhibitor of crystal growth and aggregation yet tested in undiluted human urine in vitro.
Doyle IR; Marshall VR; Dawson CJ; Ryall RL
Urol Res; 1995; 23(1):53-62. PubMed ID: 7618236
[TBL] [Abstract][Full Text] [Related]
52. Calcium oxalate crystallization index (COCI): an alternative method for distinguishing nephrolithiasis patients from healthy individuals.
Yang B; Dissayabutra T; Ungjaroenwathana W; Tosukhowong P; Srisa-Art M; Supaprom T; Insin N; Boonla C
Ann Clin Lab Sci; 2014; 44(3):262-71. PubMed ID: 25117095
[TBL] [Abstract][Full Text] [Related]
53. The alteration of urine composition due to stone material present in the urinary tract.
Laube N; Pullmann M; Hergarten S; Schmidt M; Hesse A
Eur Urol; 2003 Nov; 44(5):595-9. PubMed ID: 14572760
[TBL] [Abstract][Full Text] [Related]
54. [Stress-related alteration of urine compositions: idiopathic CaOx stone formers, patients with chronic inflammatory bowel disease (CIBD) and healthy controls].
Berg W; Uhlemann C; Meissner A; Laube N
Urologe A; 2011 Dec; 50(12):1606-13. PubMed ID: 21989587
[TBL] [Abstract][Full Text] [Related]
55. Hippuric acid as a modifier of calcium oxalate crystallisation.
Laube N; Jansen B; Schneider A; Steffes HJ; Hesse A
Clin Chem Lab Med; 2001 Mar; 39(3):218-22. PubMed ID: 11350018
[TBL] [Abstract][Full Text] [Related]
56. Comparison of the metabolic profile of mixed calcium oxalate/uric acid stone formers to that of pure calcium oxalate and pure uric acid stone formers.
Friedlander JI; Moreira DM; Hartman C; Elsamra SE; Smith AD; Okeke Z
Urology; 2014 Aug; 84(2):289-94. PubMed ID: 24929942
[TBL] [Abstract][Full Text] [Related]
57. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones.
Asplin JR; Lingeman J; Kahnoski R; Mardis H; Parks JH; Coe FL
J Urol; 1998 Mar; 159(3):664-8. PubMed ID: 9474121
[TBL] [Abstract][Full Text] [Related]
58. Calcium oxalate supersaturation increases early after Roux-en-Y gastric bypass.
Agrawal V; Liu XJ; Campfield T; Romanelli J; Enrique Silva J; Braden GL
Surg Obes Relat Dis; 2014; 10(1):88-94. PubMed ID: 23953730
[TBL] [Abstract][Full Text] [Related]
59. The paradoxical role of urinary macromolecules in the aggregation of calcium oxalate: a further plea to increase diuresis in stone metaphylaxis.
Baumann JM; Affolter B
Urolithiasis; 2016 Aug; 44(4):311-7. PubMed ID: 26920852
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of calcium oxalate crystal growth and aggregation by prothrombin and its fragments in vitro: relationship between protein structure and inhibitory activity.
Grover PK; Ryall RL
Eur J Biochem; 1999 Jul; 263(1):50-6. PubMed ID: 10429186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
